Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
9,945 total articles
Sudhanshu Chhabra, vice president of Zurn Business Systems at Zurn Elkay Water Solutions Corp (ZWS), sold 2,021 shares on February 17, 2026, to cover tax withholding tied to restricted stock unit vesting. The disposal amounted to $102,767 at prices between $50.63 and $51.22 as the stock trades close to a 52-week high. Separately, the company report…
Snap-on Inc. (NYSE: SNA) Chief Financial Officer Aldo John Pagliari sold 7,043 shares on February 19, 2026, for roughly $2.69 million and simultaneously exercised options to buy 10,000 shares at $168.70 each. The trades were carried out under a Rule 10b5-1 trading plan adopted November 3, 2025. The disclosure comes amid mixed fourth-quarter 2025 re…
IDEXX Laboratories director Sophie V. Vandebroek sold 1,464 shares of company stock on February 17, 2026, generating roughly $920,293 in proceeds, and exercised options the same day to acquire 945 shares at $333.90 each. The transactions leave her with a combination of direct and indirect holdings, while market commentary highlights a high P/E and …
Rush Street Interactive Chief Executive Officer Richard Todd Schwartz sold 247,114 Class A shares on February 17, 2026, in a transaction valued at $4.1 million executed under a pre-arranged 10b5-1 trading plan. The sale was completed at a weighted average price of $16.8151 per share, with individual trades between $16.09 and $17.06. Since that sale…
CS Disco's General Counsel and Chief Compliance Officer, Susan Garcia, reported the sale of 3,743 shares of common stock on February 17, 2026, for a total of $11,491, according to a Form 4 filing. The filing also shows that on February 18, 2026, Garcia received restricted stock unit awards totaling two separate grants of 42,910 and 41,730 shares at…
Meta Platforms director Robert M. Kimmitt completed a pre-arranged sale of 580 Class A shares on February 17, 2026, generating $370,724. The stock trades modestly higher at $644.78 and the company is valued at $1.63 trillion. The transaction was carried out under a Rule 10b5-1 plan and reported on a Form 4 filing with the SEC. Separately, Meta has …
Bloom Energy Chief Legal Officer Shawn Marie Soderberg sold 3,332 shares of Class A Common Stock on February 17, 2026, generating $465,013 in proceeds. The transaction occurred as the company’s shares have climbed 512% over the past year and trade near $159. Recent quarterly results topped expectations and prompted multiple analyst price target inc…
James Christopher Hunt, a director at Kelly Services Inc., purchased 1,000 Class A shares on February 18, 2026, for $9.5799 each. The $9,579 transaction brings his direct holdings to 5,976 shares. The trade occurs as Kelly's stock sits near its 52-week low and follows the company’s adoption of a stockholder rights plan after notification that the h…
Patrick J. Orr, Executive Vice President and Chief Revenue Officer of Healthcare Services Group Inc (NASDAQ: HCSG), sold 45,500 shares on February 18, 2026 at $20.54 per share, generating $934,570. On that same day he exercised options to acquire 45,490 shares at various strike prices, a combined exercise value of $665,344. The company posted fourt…
Deborah Stewart, Senior Vice President and Chief Accounting Officer of Aveanna Healthcare Holdings (NASDAQ: AVAH), disposed of 29,815 shares of common stock across three transactions recorded on a Form 4 filed with the Securities and Exchange Commission. The sales, executed between Feb. 17 and Feb. 19, 2026, brought in $220,196 and were reported as…
Aveanna Healthcare Holdings CEO Jeff Shaner sold 461,909 shares of company stock between February 17 and February 19, 2026, generating about $3.4 million in proceeds. The Form 4 filing shows the trades were executed to cover tax obligations tied to vested equity awards. The transactions come as Aveanna raised its fiscal 2025 revenue and net income …
Patrick A. Cunningham, Chief Compliance Officer of Aveanna Healthcare Holdings, Inc. (NASDAQ: AVAH), sold 49,160 shares between February 17 and February 19, 2026, generating roughly $363,068 in proceeds. The insider now directly holds 337,755 shares. The transactions occurred amid company updates to fiscal 2025 revenue and net income guidance and a…
Aveanna Healthcare Holdings Inc. Chief Financial Officer Matthew Buckhalter sold 36,030 shares of common stock between February 17 and February 19, 2026, for a total of $266,097. The disposals were executed to satisfy tax obligations arising from vested equity awards. The transactions occurred amid company guidance upgrades for 2025 and several ana…
MARA Holdings CEO Frederick G. Thiel sold 27,505 shares on February 17, 2026, under a Rule 10b5-1 plan, generating $210,688. The sale occurred amid a 48% decline in MARA’s stock over six months and broader weakness in Bitcoin mining names. Thiel also received 773,861 performance-vested restricted stock units that were certified on February 18, 2026…
Edwin C. Reisz, Chief Administrative Officer of Aveanna Healthcare Holdings, Inc. (NASDAQ: AVAH), sold 161,043 shares across three transactions between February 17 and February 19, 2026, generating proceeds of $1.19 million. The sales were executed to cover tax obligations tied to vested equity awards. Aveanna has also revised its 2025 revenue outl…
MARA Holdings Chief Financial Officer Khan Salman Hassan sold 16,000 shares on February 17 under a pre-arranged Rule 10b5-1 plan for $122,560, then on February 18 received 509,119 performance-vested restricted stock units that vested based on 2025 performance targets. The company's shares trade near a 52-week low amid sector volatility and recent a…
Rhythm Pharmaceuticals' Chief Financial Officer, Hunter C. Smith, sold 8,058 shares of company stock on February 17 and 19, 2026, in transactions executed under a Rule 10b5-1 plan. The trades, which generated roughly $805,813, come as the company reported preliminary fourth-quarter 2025 product revenue growth and attracted several analyst price tar…
John Kent Walker, Alphabet's President of Global Affairs and Chief Legal Officer, sold 46,975 shares of Class C capital stock on February 17, 2026, via the Arete Trust for roughly $14.3 million. The sale occurred as Alphabet shares trade around $302.85, and comes alongside company developments including a withdrawn robotaxi expansion proposal affec…
Arista Networks President and CTO Kenneth Duda sold $4.5 million of company stock on February 17, 2026, under a prearranged 10b5-1 plan, while exercising options to acquire 32,000 shares. The transactions occurred at prices between $141.1477 and $144.74, above the prevailing market price of $137.23. The company reported stronger-than-expected Q4 20…
Pacific Biosciences Chief Operating Officer Mark Van Oene sold 184,897 shares of common stock on February 17 and 18 to cover tax withholding tied to vested restricted stock units. The company reported a fourth-quarter loss narrower than analysts expected and revenue ahead of projections, prompting positive aftermarket activity. Market commentary fr…
John Christopher Shea, Executive Vice President and Chief Administrative Officer of Healthcare Services Group Inc (HCSG), exercised options to acquire 38,857 shares and sold 54,357 shares on February 18, 2026. The disposition generated roughly $1.1 million in proceeds, while the option exercises involved $662,674. The company recently reported a si…
Christian O. Henry, President and CEO of Pacific Biosciences of California, Inc. (NASDAQ: PACB), sold a total of 472,667 shares of common stock on February 17 and 18, 2026, to satisfy tax withholding tied to restricted stock units. The two transactions generated proceeds of about $752,389. After the sales, Henry retains direct ownership of 2,673,50…
Michele Farmer, Chief Accounting Officer at Pacific Biosciences of California, sold 50,167 shares of the company’s common stock on February 17 and 18, 2026, to satisfy tax withholding obligations tied to the vesting of restricted stock units. The transactions totaled about $79,855. Pacific Biosciences recently reported fourth-quarter 2025 results t…
CoreWeave Chief Development Officer Brannin McBee sold 5,624 shares of Class A common stock on February 17, 2026, generating $504,977 in proceeds under a Rule 10b5-1 trading plan. On the same day, McBee converted 5,000 shares of Class B common stock held in trust into Class A shares without a cash exchange. The trades took place amid a stock price …
CoreWeave Chief Development Officer McBee Brannin sold $3.05 million of Class A common stock on February 17, 2026, through two family grantor retained annuity trusts (Canis Major 2025 GRAT and Canis Minor 2025 GRAT). The transactions, executed at weighted-average prices between $89.84 and $95.38, coincided with conversions of Class B shares to Clas…
